SCHEMBL14295437

SCHEMBL14295437

c1ccc(-c2ccc(N(c3ccc(-c4ccccc4)cc3)c3ccc(-c4ccc(N(c5ccc6oc7ccccc7c6c5)c5ccc6oc7ccccc7c6c5)cc4)cc3)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.47
MAPT P10636 4/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
NPC1 O15118 3/20 0.47
KDM4E B2RXH2 3/20 0.47
ALDH1A1 P00352 3/20 0.47
RAB9A P51151 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
PLA2G2A P14555 5/20 0.44
PLA2G4A P47712 5/20 0.44
AHR P35869 2/20 0.43
TNKS O95271 2/20 0.40
CYP3A4 P08684 2/20 0.40
GABRP O00591 1/20 0.40
GABRD O14764 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14295461 1.00 HPGD (0.47) HPGDMAPTSMN1; SMN2NPC1KDM4E
SCHEMBL29362212 1.00 HPGD (0.47) HPGDMAPTSMN1; SMN2NPC1KDM4E
SCHEMBL14295283 1.00 HPGD (0.47) HPGDMAPTSMN1; SMN2NPC1KDM4E
SCHEMBL15964355 1.00 HPGD (0.47) HPGDMAPTSMN1; SMN2NPC1KDM4E
SCHEMBL16804569 1.00 HPGD (0.47) HPGDMAPTSMN1; SMN2NPC1KDM4E
SCHEMBL16639222 1.00 HPGD (0.47) HPGDMAPTSMN1; SMN2NPC1KDM4E
SCHEMBL17126360 1.00 HPGD (0.47) HPGDMAPTSMN1; SMN2NPC1KDM4E
SCHEMBL14295447 1.00 HPGD (0.47) HPGDMAPTSMN1; SMN2NPC1KDM4E
SCHEMBL20906759 1.00 HPGD (0.47) HPGDMAPTSMN1; SMN2NPC1KDM4E
SCHEMBL15178624 1.00 HPGD (0.47) HPGDMAPTSMN1; SMN2NPC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120319091-A1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-12-20 US disclosed
US-20120319091-A1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120319091-A1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME INMT, TYR, ALKBH2 HPGD 4319/4885MAPT 271/4885SMN1; SMN2 3384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.